CPCM
GILD icon

Cardinal Point Capital Management’s Gilead Sciences GILD Stock Holding History

Cardinal Point Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
9,748
-300
-3% -$39.5K 0.07% 113
2026
Q1 		$1.4M Sell
10,048
-275
-3% -$38.5K 0.09% 101
2025
Q4 		$1.27M Sell
10,323
-500
-5% -$60.8K 0.08% 105
2025
Q3 		$1.2M Sell
10,823
-1,060
-9% -$120K 0.08% 106
2025
Q2 		$1.32M Sell
11,883
-75
-0.6% -$7.98K 0.1% 89
2025
Q1 		$1.34M Buy
+11,958
New +$1.23M 0.12% 81

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cardinal Point Capital Management's GILD Position: Q2 2026 in Review

Cardinal Point Capital Management reduced its Gilead Sciences (GILD) stake by 3% in Q2 2026, selling an estimated $39.5K and leaving 9,748 shares worth $1.23M. The position accounts for 0.07% of the portfolio, ranked #113.

Cardinal Point Capital Management first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.4M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cardinal Point Capital Management held 9,748 shares of Gilead Sciences worth $1.23M as of Q2 2026.
  • Cardinal Point Capital Management sold 300 Gilead Sciences shares in Q2 2026, an estimated $39.5K.
  • Gilead Sciences made up 0.07% of Cardinal Point Capital Management's portfolio in Q2 2026, its #113 holding.
  • Cardinal Point Capital Management first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Cardinal Point Capital Management's Gilead Sciences position peaked at $1.4M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cardinal Point Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.